What changed: Desmoid tumour
Every dated change on the records linked to Desmoid tumour, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Approval2Regulatory1Trial result1Guideline1Milestone6This record1
September 2026 · 1
2025 · 1
November 2023 · 1
2023 · 2
2022 · 1
2020 · 2
- 2020GuidelineDesmoid tumourGuideline Desmoid Tumor Working Group consensus (Eur J Cancer 2020); NCCN Soft Tissue Sarcoma: Newly diagnosed, asymptomatic or minimally symptomatic
Active surveillance with MRI at 1 to 2 months, then every 3 to 6 months; treat only on progression or symptoms. (NCCN Category 2A (observation))
- 2020MilestoneActive surveillanceDesmoid Tumor Working Group consensus
Active surveillance as initial management for most patients (Eur J Cancer).